Gepirone

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C19H29N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JW5Y7B8Z18, chemically known as 3,3-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)glutarimide monohydrochloride but generally known as gepirone, which bears US NIH Compound Identifier 55190. European Medicines Agency schedules Gepirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07897MIG. The term GEPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). World Health Organization schedules gepirone in its Anatomical Therapeutic Chemical (ATC) Classification. GEPIRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gepirone under HS 29335995 and SITC 51576. As of Q4 2014, GEPIRONE remains the US FDA Preferred Term for this commodity. Gepirone bears US NLM identifiers UMLS ID C0066624 and NCI Concept Code C74193. SMILES: Cl.O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)CC(C1)(C)C.